DEFA14A: UNFI Seeks Shareholder Approval for Equity Plan Boost

United Natural Foods, Inc. is seeking stockholder approval for an increase of 1,500,000 shares in its 2020 Equity Incentive Plan to align executive compensation with long-term interests.

Summary

• Seeking stockholder approval for the Fifth Amended and Restated 2020 Equity Incentive Plan.
• Requesting an increase of 1,500,000 shares available for issuance under the plan.
• The plan aims to align executive compensation with long-term stockholder interests and the achievement of the Company's strategic initiatives.
• Expects to have sufficient shares to issue equity awards in December 2025 but needs the additional shares to return to the normal October 2026 grant cadence.
• Highlights responsiveness to stockholder feedback, prudent grant practices, and actions taken to mitigate dilution concerns.
• Institutional Shareholder Services (ISS) recommended against the proposal, citing quantitative analysis and discretion in change-in-control vesting.
• Glass Lewis recommended for the proposal, acknowledging factors impacting dilution and the Board's actions to mitigate stockholder concerns.

Sentiment

Score: 6

Explanation: The filing presents a generally positive case for the equity plan, emphasizing alignment with stockholder interests and prudent practices. However, the negative recommendation from ISS and the inherent dilution challenges due to lower market capitalization introduce a degree of caution, preventing a higher score. The company is proactively addressing concerns and has a history of stockholder approval for its compensation.

Positives

• Demonstrated thoughtful responsiveness to stockholder feedback in the equity plan and executive compensation program.
• Executive compensation program is designed to align with long-term stockholder interests and strategic initiatives.
• Achieved 93.9% approval for the Say-on-Pay vote last year.
• Maintains a history of prudent grant practices, with fiscal 2025 stock compensation expense approximating peer groups' 55th and 45th percentile as a percent of revenue.
• Implemented actions to mitigate dilution concerns, including issuing cash-settled awards in fiscal 2025 (improving burn rate by 1.5%).
• Performance-based compensation is heavily weighted, with PSUs constituting 60% of executives' total long-term incentive awards.
• Shares withheld for taxes are not resold or returned to the plan (approximately 444,000 shares in fiscal 2025, representing 0.7% of total common shares outstanding).
• Authorized a share repurchase program in September 2022 for up to $200 million of common stock over four years to help manage dilution.
• Compensation program reflects ongoing stockholder feedback and has been revised over several years.
• Short-term incentive program is tied to Adjusted EBITDA and Free Cash Flow (replacing Net sales in fiscal 2025).
• Long-term incentives (RSUs and PSUs) are designed to attract and retain innovative executives, with fiscal 2025 PSUs weighted on Core Adjusted EPS and Free Cash Flow.
• Glass Lewis acknowledged the factors impacting dilution and the Board's mitigation actions, recommending a vote for the Fifth Amended and Restated Plan.

Negatives

• Institutional Shareholder Services (ISS) recommended against the approval of the Fifth Amended and Restated Plan.
• ISS noted that the change-in-control vesting treatment is discretionary and allows broad discretion to accelerate vesting.
• The company's market capitalization is lowest among its peers, leading to higher dilution and burn rate when delivering competitive compensation value.

Risks

• Inability to attract and retain strong talent if competitive levels of equity compensation cannot be paid, potentially impacting the company's multi-year strategy.
• A vote against Proposal 4 could weaken the competitiveness of the overall executive compensation program.
• Risk of losing strong talent if the executive compensation program is not competitive.
• Potential negative impact to the multi-year strategy if strong talent cannot be attracted or retained.

Future Outlook

The company expects to request shares again in fiscal 2027 to make its fiscal 2028 award, indicating a continued reliance on equity compensation. The approval of Proposal 4 is deemed necessary to maintain a competitive executive compensation program and support the multi-year strategic plan, with a goal to return to an October grant date in 2026.

Management Comments

• "We have demonstrated thoughtful responsiveness to stockholder feedback in our equity plan and executive compensation program."
• "Without the ability to pay our associates with equity, our associates interests will not be as aligned with our stockholders long-term interests, which our stockholders have told us is important to them."
• "We believe that providing at-risk, equity-based compensation is a fundamental component of our compensation program."
• "We continue to be mindful of stockholder feedback regarding dilution concerns and have taken several actions in response."
• "A vote against Proposal 4 could effectively weaken the competitiveness of our overall executive compensation program, which could create a risk of losing strong talent and result in a negative impact to our multi-year strategy."
• "The approval of additional shares is necessary for the Company to continue to compensate our Directors and equity-eligible associates in a manner that has been consistently approved by our stockholders and on a timeline that aligns more closely with the end of our fiscal year."

Industry Context

The company operates a larger and more complex business than many of its peers, as evidenced by its 71st percentile revenue size. Despite this, its market capitalization is among the lowest in its peer group, which results in higher dilution when delivering competitive equity compensation. The company's compensation practices, including the use of Free Cash Flow as a key metric, reflect a focus on capital management and operational excellence, aligning with broader industry trends towards performance-based incentives.

Comparison to Industry Standards

• The company's compensation program is in line with market compensation, but its relatively low market capitalization compared to its Comparator Group (lowest among peers) results in elevated dilution and burn rate.
• For fiscal 2025, the company's stock compensation expense approximated its peer groups' 55th and 45th percentile as a percent of revenue, demonstrating responsible share usage despite the dilution challenges.
• The company's outstanding share count was approximately 51% of the median number of outstanding shares reported by the Comparator Group, highlighting the impact of its lower market capitalization on share usage for compensation.
• Institutional Shareholder Services (ISS) recommended against the plan based on quantitative analysis, while Glass Lewis acknowledged the company's specific dilution factors and recommended for the plan, indicating differing interpretations of industry standards for equity compensation.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased dilution due to additional share issuance, but also potential for enhanced long-term value creation through aligned management incentives and talent retention. The share repurchase program aims to manage dilution.
• Employees (Directors and equity-eligible associates): Continued ability to receive equity-based compensation, aligning their interests with company performance and providing retention incentives.
• Management: The ability to maintain a competitive compensation program is crucial for attracting and retaining strong talent, which is vital for executing the multi-year strategy.

Next Steps

• Stockholders are urged to vote FOR Proposal 4 at the Annual Meeting on December 16, 2025.
• Company expects to issue equity awards to Directors and equity-eligible associates in December 2025.
• Company aims to return to its normal October grant date in 2026 for equity awards.
• Company expects to request shares again in fiscal 2027 for fiscal 2028 awards.

Key Dates

Recommendation

The filing primarily concerns a routine corporate governance matter—seeking approval for an increase in shares for an equity incentive plan. While the company highlights its efforts to align compensation with performance and address dilution concerns, the negative recommendation from ISS introduces a point of contention. The company's rationale for needing the shares for talent retention and strategic execution is sound, but the dilution aspect is a persistent challenge due to its market capitalization relative to peers. There are no new financial results or strategic shifts that would warrant a 'buy' or 'sell' recommendation based solely on this supplement. Investors should 'hold' and monitor the outcome of the vote and the company's ongoing performance and dilution management strategies.

Keywords

Equity Incentive Plan, Stockholder Approval, Executive Compensation, Share Dilution, Corporate Governance, Proxy Statement, UNFI, United Natural Foods, Performance Stock Units, Restricted Stock Units, Share Repurchase, Free Cash Flow, Adjusted EBITDA, Core Adjusted EPS